Abstract:Heart disease involves irreversible myocardial injury that leads to high morbidity and mortality rates. Numerous cell-based cardiac in vitro models have been proposed as complementary approaches to non-clinical animal research. However, most of these approaches struggle to accurately replicate adult human heart conditions, such as myocardial infarction and ventricular remodeling pathology. The intricate interplay between various cell types within the adult heart, including cardiomyocytes, fibroblasts, and endothelial cells, contributes to the complexity of most heart diseases. Consequently, the mechanisms behind heart disease induction cannot be attributed to a single-cell type. Thus, the use of multi-cellular models becomes essential for creating clinically relevant in vitro cell models. This study focuses on generating self-organizing heart organoids (HOs) using human-induced pluripotent stem cells (hiPSCs). These organoids consist of cardiomyocytes, fibroblasts, and endothelial cells, mimicking the cellular composition of the human heart. The multi-cellular composition of HOs was confirmed through various techniques, including immunohistochemistry, flow cytometry, q-PCR, and single-cell RNA sequencing. Subsequently, HOs were subjected to hypoxia-induced ischemia and ischemia-reperfusion (IR) injuries within controlled culture conditions. The resulting phenotypes resembled those of acute myocardial infarction (AMI), characterized by cardiac cell death, biomarker secretion, functional deficits, alterations in calcium ion handling, and changes in beating properties. Additionally, the HOs subjected to IR efficiently exhibited cardiac fibrosis, displaying collagen deposition, disrupted calcium ion handling, and electrophysiological anomalies that emulate heart disease. These findings hold significant implications for the advancement of in vivo-like 3D heart and disease modeling. These disease models present a promising alternative to animal experimentation for studying cardiac diseases, and they also serve as a platform for drug screening to identify potential therapeutic targets.

Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography

Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells

Deep learning based characterization of human organoids using optical coherence tomography

A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization

Micropatterned Organoids Enable Modeling of the Earliest Stages of Human Cardiac Vascularization

Human heart-forming organoids recapitulate early heart and foregut development

Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.

Dual-modality imaging system for monitoring human heart organoids beating in vitro

Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease

Self-Assembled Chambered Cardiac Organoids for Modeling Cardiac Chamber Formation and Cardiotoxicity Assessment

Unveiling New Horizons in Heart Research: the Promise of Multi-Chamber Cardiac Organoids

Self-assembly vascularized human cardiac organoids model cardiac diseases in petri dishes and in mice

Cardiac Organoid — a Promising Perspective of Preclinical Model

Cardioids reveal self-organizing principles of human cardiogenesis

Improving human cardiac organoid design using transcriptomics

Single-cell Atlas of Multilineage Cardiac Organoids Derived from Human Induced Pluripotent Stem Cells

Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture

Generation of Human Vascularized and Chambered Cardiac Organoids for Cardiac Disease Modelling and Drug Evaluation.

Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids

Advances in Cardiac Organoids

Generation of vascularized human cardiac organoids for 3D in vitro modeling